Search results :

Pimecrolimus

More information: STITCH, PubChem (stereo-specific compounds: 1, 2) and possibly Wikipedia

ATC Code: D11AH02

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Headache Headache 7.01% - 25.4% x x x x x x x
Nervous system disorder Nervous system disorder 7.01% - 25.4% x x x x x x x
Upper respiratory tract infection Upper respiratory tract infection 4.27% - 19.4% x x x x x
Infestation Infestation NOS 4.27% - 19.4% x x x x x x
Infection Infection 4.27% - 19.4% x x x x x x x
Mediastinal disorder Mediastinal disorder 2.44% - 15.8% x x x x x x
Nasopharyngitis Nasopharyngitis 7.35% - 26.5% x x x x x x x
Rhinorrhoea 0% - 1.9% x x x x x x x
Application site pain Application site burn 1.49% - 25.9% x x x x x x x x
Application site burn Application site burn 1.49% - 25.9% x x x x x x x x
Cough Cough 2.4% - 15.8% x x x x x x x
Body temperature increased Body temperature increased 1.2% - 12.5% x x x x x x x
Influenza Influenza 0.7% - 13.2% x x x x x x x
Skin infection Skin infection common, 2.2% - 6.62% x x x x x x x x
Erythema Erythema common x
Gastrointestinal disorder Gastrointestinal disorder 0.305% - 6.67% x x x x x x x
Immune system disorder Immune system disorder 1.33% - 5.15% x x x x x x x x
Vomiting Vomiting 0.6% - 8% x x x x x x x
Hypersensitivity Hypersensitivity postmarketing — 1.3% - 5.15% x x x x x x x x
Abdominal pain upper Abdominal pain upper 0.3% - 6.7% x x x x x x x
Oropharyngeal discomfort Throat sore 1.22% - 8.1% x x x x x x x
Oropharyngeal pain Throat sore 1.22% - 8.1% x x x x x x x
Impetigo Impetigo 1.87% - 5.33% x x x x x x x x
Application site reaction Application site reaction 0.61% - 14.6% x x x x x x x
Application site irritation Application site irritation 0.368% - 6.4% x x x x x x x
Otitis media Otitis media 0.6% - 5.33% x x x x x x x
Pruritus Pruritus postmarketing, common x x
Asthma Asthma 0.299% - 3.7% x x x x x x x
Asthma aggravated 0% - 3.9% x x x x x x x
Bronchitis Bronchitis 0.375% - 10.7% x x x x x x x
Acute bronchitis 0% - 1.5% x x x x x x x
Folliculitis Folliculitis common, 0.7% - 20% x x x x x x x x
Eye disorder Eye disorder 0.735% - 4% x x x x x x x
Conjunctivitis Other conjunctivitis 0.299% - 4% x x x x x x x
Herpes simplex Herpes simplex 0% - 4% x x x x x x x x
Ear infection Ear infection 0.6% - 5.7% x x x x x x x
Gastroenteritis Gastroenteritis 0% - 7.4% x x x x x x x
Nausea Nausea 0.375% - 6.7% x x x x x x x
Rhinitis Rhinitis 0% - 6.7% x x x x x x x
Nasal congestion Nasal congestion 0.305% - 2.62% x x x x x x x
Bacterial infection Bacterial infection 0% - 2.21% x x x x x x x
Sinusitis Sinusitis 0.6% - 11% x x x x x x x
Breast disorder Breast disorder 0% - 1.49% x x x x x x x
Diarrhoea Diarrhoea 0.299% - 7.72% x x x x x x x
Loose stools 0% - 1.2% x x x x x x x
Dysmenorrhoea Dysmenorrhoea 0% - 1.5% x x x x x x x
Application site pruritus Application site pruritus 0% - 5.5% x x x x x x
Pneumonia Pneumonia 0% - 1.5% x x x x x x x
Pharyngitis Pharyngitis 0.7% - 8.1% x x x x x x x
Staphylococcal infection Staphylococcal infection 0% - 3.7% x x x x x x x
Varicella Varicella 0% - 4% x x x x x x x
Abdominal pain Abdominal pain 0.299% - 4.41% x x x x x x x
Gastrointestinal pain Abdominal pain 0.299% - 4.41% x x x x x x x
Rhinorrhoea Rhinorrhoea 0% - 1.9% x x x x x x x
Viral infection Viral infection 0% - 6.62% x x x x x x x
Ear pain Ear pain 0% - 2.94% x x x x x x x
Sinus congestion Sinus congestion 0.299% - 1.12% x x x x x x x
Influenza like illness Influenza like illness 0% - 2.7% x x x x x x x
Pharyngitis streptococcal Pharyngitis streptococcal 0% - 3% x x x x x x x
Toothache Toothache 0.299% - 2.6% x x x x x x x
Laceration Laceration 0% - 1.5% x x x x x x x
Acne Acne 0% - 1.83% x x x x x x x
Wheezing Wheezing 0% - 1.2% x x x x x x x
Back pain Back pain 0% - 1.83% x x x x x x x
Skin papilloma Skin papilloma 0% - 3.31% x x x x x x x x
Bone disorder Bone disorder 0% - 1.83% x x x x x x x
Constipation Constipation 0% - 3.7% x x x x x x x
Urticaria Urticaria postmarketing — 0% - 1.12% x x x x x x x x
Molluscum contagiosum Molluscum contagiosum 0% - 1.84% x x x x x x x x
Viral upper respiratory tract infection Viral upper respiratory tract infection 0% - 1.5% x x x x x x
Epistaxis Epistaxis 0% - 3.31% x x x x x x x
Arthralgia Arthralgia 0% - 1.52% x x x x x x x
Musculoskeletal discomfort Arthralgia 0% - 1.52% x x x x x x x
Herpes dermatitis Herpes simplex dermatitis 0% - 1.5% x x x x x x x x
Application site erythema Application site erythema 0% - 2.21% x x x x x x x
Dyspnoea Dyspnoea 0% - 1.84% x x x x x x x
Eye infection Eye infection 0% - 1.1% x x x x x x x
Anaphylactic shock Anaphylactic shock postmarketing x x x x x
Angioedema Angioedema postmarketing, rare x x x x x
Neoplasm malignant Neoplasm malignant postmarketing x x
Basal cell carcinoma Basal cell carcinoma postmarketing x x x x
Squamous cell carcinoma Squamous cell carcinoma postmarketing x x x x
Dermatitis exfoliative Dermatitis exfoliative postmarketing x
Dermatitis Rash postmarketing, rare x x
Rash Rash postmarketing, rare x x
Flushing Flushing postmarketing x x x x x
Lymphoma Lymphoma postmarketing x x x x x
Non-Hodgkin's lymphoma Lymphoma postmarketing x x x x x
Malignant melanoma Malignant melanoma postmarketing x x x x
Neoplasm skin Neoplasm skin postmarketing x
Swelling Swelling postmarketing x x
Alcohol intolerance Alcohol intolerance postmarketing, rare x x
Skin discolouration Skin discolouration postmarketing, rare x x x x
Skin hyperpigmentation Skin hyperpigmentation postmarketing, rare x x
Leukoderma Leukoderma postmarketing, rare x x
Eye irritation Eye irritation postmarketing x x x
Face oedema Face oedema postmarketing x x x
Skin cancer Skin cancer x
Oedema Oedema x
Malignant histiocytosis Malignant histiocytosis x
Extranodal NK/T-cell lymphoma, nasal type Malignant histiocytosis x
Leukaemia Leukaemia x
Pain Pain x
Paraesthesia Paraesthesia x
Superinfection Superinfection x x x x x x x
Tonsillitis Tonsillitis 0% - 6.3% x x x x x x x
Tracheobronchitis Acute bronchitis 0% - 1.5% x x x x x x x
Skin atrophy Skin atrophy x
Malnutrition Malnutrition x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Condition aggravated Condition aggravated x
Skin exfoliation Skin exfoliation x
Furuncle Furuncle x
Colon cancer Carcinoma colon x
Eczema herpeticum Eczema herpeticum x
Sensitisation Sensitisation x x x x x x x
Photosensitivity reaction Phototoxicity x x x x x x x
Arthritis bacterial Arthritis bacterial x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ELIDEL / Elidel, Topical cream

Side effects:34
Source:Medsafe

PIMECROLIMUS / ELIDEL

Side effects:74
Source:FDA

PIMECROLIMUS / ELIDEL

Side effects:75
Source:FDA

PIMECROLIMUS

Side effects:76
Source:FDA Structured Product Label

PIMECROLIMUS / ELIDEL

Side effects:84
Source:FDA

Pimecrolimus

Side effects:86
Source:FDA Structured Product Label

PIMECROLIMUS / ELIDEL

Side effects:86
Source:FDA

PIMECROLIMUS / ELIDEL

Side effects:92
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label